Desenfriol-D
- Product NDC
- 53666-517
- 11-digit product format
- 536660517
- Labeler code
- 53666
- Product ID
- 53666-517_c57557fd-d7a1-1337-e053-2995a90a143d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Salimex, S.A.
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2017-10-18
- Marketing end
- 0000-00-00
- Substance
- CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN
- Active strength
- 0 g/g; g/g; g/g
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53666-517-01 | Desenfriol-D | 30 in 1 BOX | TABLET | 30 | | 5 |
| 53666-517-01 | Desenfriol-D | 0.05 g in 1 BLISTER PACK | TABLET | 0.05 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53666-517 | DESENFRIOL-D (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN) TABLET [SALIMEX, S.A.] | 5 | Legacy NDC, 2 package rows | 20210626_5bed9460-0222-127c-e053-2991aa0a8ae0.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53666-517-01 | 53666051701 | 30 BLISTER PACK in 1 BOX (53666-517-01) > .05 g in 1 BLISTER PACK | 30 blister pack | 2017-10-18 | 0000-00-00 | No | No | Current |